We will rely on you to help lend your voice and support the biotechnology industry.
Learn more about BIO initiatives to advance the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO CEO & Investor Conference
February 12-13, 2018
BIO IP Counsels Committee Conference
April 11-13, 2018
BIO Industry Analysis Reports
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
July 16 - 19, 2018 | Philadelphia, Pennsylvania
Jenny Rooke brings a combination of strategy, operating, and investing experience to her work with life sciences companies, specializing in research tools, diagnostics, and synthetic biology. Dr. Rooke is founder and Managing Director of Genoa Ventures, which invests in early-stage companies innovating at the intersection of biology and technology. Her previous investing roles include Venture Partner at F-Prime Capital (formerly Fidelity Biosciences), where she also served her Kauffman Fellowship, and Anterra Capital, the world’s largest food and Ag-focused fund. Previously, Jenny served as a Senior Program Officer of the Global Health Discovery group at the Bill & Melinda Gates Foundation. Operationally, she held multiple executive positions at U.S. Genomics, a venture-backed biotech start-up advancing single molecule detection technologies for diagnostics, biodefense, and research. Jenny made her transition from the lab to business as a management consultant with McKinsey & Co., where she advised leading pharmaceutical and biotech companies on business strategy. Jenny earned her Ph.D. in genetics from Yale University and her B.S. in physics from Georgia Tech.
This speaker's sessions: